TherapeuticsMD, Inc. Financial Ratios — TXMD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-105.19	-152.67	-94.33	-59.77	-116.62	-330.09	- -	- -	- -	-31.9	-7.7	-2.1
Return on Assets (%)	-979.78	-953.76	-83.66	-89.54	-128.12	-83.14	-53.85	-74.67	-73.71	-82	-98.22	86.17	-15.37	-5.31	-1.49
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	151.37	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.54	- -	- -	- -
Gross Margin (%)	54.64	64.69	77.67	75.56	77.63	78.38	84.28	83	87.24	75.37	45.51	98	100	100	100
EBITDA Margin (%)	-257.28	-421.48	-293.43	-359.3	-422.62	-465.59	-461.42	-807.02	-301.76	-233.5	-3,064.17	16.96	-583.79	-202.39	-99.97
Operating Margin (%)	-259.9	-422.95	-294.09	-359.65	-422.93	-466.27	-462.69	-808.85	-304.56	-239.77	-3,092.77	15.24	-654.61	-275.07	-139.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	133.91	15.24	- -	- -
Pretax Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-3,082.2	1.54	-594.62	-133.05	-21.61
Profit Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-6,700.93	160.08	-789.4	-123.85	-18.83
Net Income to Common Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-6,700.93	160.08	-789.4	-123.85	-18.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-105.19	-152.67	-94.33	-59.77	-116.62	-330.09	- -	- -	- -	-31.9	-7.7	-2.1

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	4	- -	- -	- -	- -	- -	73	205	249	198	9	8	7	6
ST Debt	2	- -	- -	- -	- -	- -	- -	- -	2	2	190	1	1	2	1
LT Debt	- -	4	- -	- -	- -	- -	- -	73	204	246	8	7	7	6	5
Total Debt/EBITDA	-0.44	-0.22	- -	- -	- -	- -	- -	-0.56	-1.37	-1.64	-2.51	0.74	-1.05	-2.01	-2.02
Net Debt/EBITDA	-0.41	-0.13	2.1	0.95	0.76	1.46	1.64	0.68	-0.23	-1.04	-1.56	-3.21	0.57	1.42	2.48
Total Debt/EBIT	-0.43	-0.22	- -	- -	- -	- -	- -	-0.56	-1.36	-1.6	-2.48	0.82	-0.94	-1.48	-1.45
Net Debt/EBIT	-0.41	-0.13	2.1	0.95	0.76	1.46	1.64	0.68	-0.22	-1.01	-1.55	-3.57	0.51	1.04	1.78
EBITDA to Interest Expense	-83.45	-8.45	-9.64	-207.63	- -	- -	- -	-27.77	-9.07	-5.81	-3.49	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-84.03	-8.59	-9.82	-210	- -	- -	- -	-32.33	-10.51	-5.88	-3.59	- -	- -	- -	- -
EBIT to Interest Expense	-84.3	-8.48	-9.67	-207.83	- -	- -	- -	-27.84	-9.15	-5.97	-3.53	- -	- -	- -	- -
Interest Expense	- -	2	3	- -	- -	- -	- -	5	17	26	23	- -	- -	- -	- -
Common Equity/Total Assets	-118.98	-24.18	88.2	81.91	85.53	89.48	90.7	46.01	3.46	-68.28	-55.24	38.85	67.62	70.5	71.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	75.24	2,214.73	- -	- -	20.97	22.3	20.25	19.06
Long-Term Debt/Capital (%)	- -	166.47	- -	- -	- -	- -	- -	42.94	95.01	197.69	7.75	16.79	17.52	16.04	15.53
Long-Term Debt/Total Assets (%)	- -	60.57	- -	- -	- -	- -	- -	34.62	76.61	135.66	4.76	8.15	15.08	14.28	13.6
Total Debt/Equity (%)	-137.28	-250.44	- -	- -	- -	- -	- -	75.24	2,231.05	-200.5	-211.16	24.92	27.33	26.21	22.69
Total Debt/Capital (%)	368.26	166.47	- -	- -	- -	- -	- -	42.94	95.71	199.5	189.96	19.95	21.47	20.77	18.49
Total Debt/Total Assets (%)	163.34	60.57	- -	- -	- -	- -	- -	34.62	77.18	136.9	116.65	9.68	18.48	18.48	16.19
Net Debt to Equity	-129.89	-142.05	-99.07	-106.14	-102.61	-103.17	-97.87	-90.47	367.4	-126.78	-131.77	-108.32	-14.77	-18.48	-27.84
Net Debt/Capital (%)	434.53	337.84	-10,685.51	1,727.89	3,937.8	3,252.03	-4,584.62	-949.54	63.01	356.17	314.98	-652.39	-13.13	-17.16	-29.36
EBITDA	-5	-16	-26	-54	-85	-90	-77	-130	-150	-151	-79	12	-8	-4	-3
EBITDA-CapEx	-5	-16	-26	-55	-86	-91	-78	-151	-174	-153	-81	12	-8	-4	-3
Operating Income (Loss)	-5	-16	-26	-54	-85	-90	-78	-130	-151	-156	-80	11	-9	-5	-4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.04	0.43	7.41	4.8	6.07	8.78	9.54	3.93	3.03	1.36	0.26	0.81	0.63	0.98	1.56
Current Ratio	0.39	1.28	8.12	5.26	6.63	9.3	10.48	4.55	3.93	2.17	0.47	1.18	1.72	2.37	3.02
Quick Ratio	0.05	0.63	7.67	5.03	6.35	9.08	9.87	4.2	3.49	1.91	0.4	0.81	1.08	1.67	2.3
CFO/Avg Current Liab	-2.94	-3.76	-3.8	-5.06	-7.4	-5.39	-5.38	-3.93	-3.52	-2.84	-0.91	0.06	-0.86	0.19	0.49
Common Equity/Total Assets	-118.98	-24.18	88.2	81.91	85.53	89.48	90.7	46.01	3.46	-68.28	-55.24	38.85	67.62	70.5	71.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	75.24	2,214.73	- -	- -	20.97	22.3	20.25	19.06
Long-Term Debt/Capital (%)	- -	166.47	- -	- -	- -	- -	- -	42.94	95.01	197.69	7.75	16.79	17.52	16.04	15.53
Long-Term Debt/Total Assets (%)	- -	60.57	- -	- -	- -	- -	- -	34.62	76.61	135.66	4.76	8.15	15.08	14.28	13.6
Total Debt/Equity (%)	-137.28	-250.44	- -	- -	- -	- -	- -	75.24	2,231.05	-200.5	-211.16	24.92	27.33	26.21	22.69
Total Debt/Capital (%)	368.26	166.47	- -	- -	- -	- -	- -	42.94	95.71	199.5	189.96	19.95	21.47	20.77	18.49
Total Debt/Total Assets (%)	163.34	60.57	- -	- -	- -	- -	- -	34.62	77.18	136.9	116.65	9.68	18.48	18.48	16.19
CFO/Total Liabilities	-157.64	-173.08	-283.79	-425.81	-741.11	-461.48	-571.69	-93.32	-64.54	-52.18	-54.24	16.92	-164.61	10.22	22.76
CFO/CapEx	-131.96	-46.74	-43.28	-73.73	-135.27	-55.7	-92.07	-5.01	-6.94	-99.79	-64.19	26.36	- -	- -	- -
Altman's Z-Score	-6.74	3.9	59.87	33.85	96.91	41.43	54.39	-0.34	-4.05	-10.67	-11.3	-13.79	-35.18	-38.27	-38.27

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	108.39	10.3	7.3	7.82	7.74	5.13	3.8	2.09	2.8	2.29	0.08	3.87	- -	- -	- -
Days Sales Outstanding	3.37	35.43	50.02	46.7	47.15	71.19	96.04	174.49	130.35	159.73	4,862.74	94.37	- -	- -	- -
Inventory Turnover	1.57	1.22	1.47	3.3	4.81	4.74	2.06	1.15	0.84	1.61	0.18	0.37	- -	- -	- -
Days Inventory Outstanding	232.41	298.27	247.62	110.63	75.82	77.02	177.29	316.85	435.82	226.81	2,032.62	995.72	- -	- -	- -
Accounts Payable Turnover	4.32	2.44	0.74	0.9	0.85	0.87	0.53	0.34	0.71	0.6	0.08	-2.25	- -	- -	- -
Accounts Payable Turnover Days	84.4	149.66	493.8	404.31	429.73	418.53	686.39	1,083.76	512.55	606.7	4,326.37	-162.27	- -	- -	- -
Cash Conversion Cycle	151.38	184.03	-196.16	-246.99	-306.76	-270.32	-413.06	-592.42	53.62	-220.16	2,569	1,252.35	- -	- -	- -
Inventory to Cash Days	-229.05	-262.84	-197.6	-63.93	-28.67	-5.83	-81.25	-142.36	-305.47	-67.08	2,830.12	-901.35	- -	- -	- -
Inventories	1	2	1	1	1	1	1	3	12	8	8	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	6	4	3	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	- -	- -	- -	- -
Finished Goods	1	1	1	1	1	1	1	3	5	3	3	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	124	309	755	695	1,845	1,135	1,307	916	656	363	155	53	26	10	19
- Cash & Cash Equivalents	- -	2	54	51	65	132	127	162	161	80	65	38	4	5	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	4	- -	- -	- -	- -	- -	73	205	249	198	9	8	7	6
Enterprise Value	127	311	701	643	1,780	1,003	1,180	828	701	531	288	24	30	12	17
Total Capital	1	2	55	48	63	127	130	171	214	125	104	44	37	35	33
Total Debt/Capital (%)	368.26	166.47	- -	- -	- -	- -	- -	42.94	95.71	199.5	189.96	19.95	21.47	20.77	18.49
Total Debt / EV	0.02	0.01	- -	- -	- -	- -	- -	0.09	0.29	0.47	0.69	0.37	0.27	0.6	0.35
EV/Sales	60.67	81.55	79.9	42.81	88.39	51.84	70.34	51.43	14.11	8.18	111.75	0.34	22.75	6.83	5.78
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.01	25.48	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.23	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.54	- -	10.29	7.12
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.45	- -	10.29	7.12
Diluted Market Cap	94	284	665	666	1,796	1,131	1,241	857	596	334	143	52	23	10	19
Diluted Enterprise Value	96	286	610	615	1,731	1,000	1,114	769	641	502	276	23	27	12	17
EV per Share	76.34	156.02	241.81	206.05	500.32	255.06	272.63	172.15	129.2	88.55	33.44	2.5	2.57	1.04	1.51
TTM Sales	2	4	9	15	20	19	17	16	50	65	3	70	1	2	3
TTM EBITDA	-5	-16	-26	-54	-85	-90	-77	-130	-150	-151	-79	12	-8	-4	-3
TTM Operating Income	-5	-16	-26	-54	-85	-90	-78	-130	-151	-156	-80	11	-9	-5	-4
TTM Cash Flow to Firm	-5	-11	-18	-45	-79	-69	-76	-102	-149	-133	-120	9	-23	1	2
TTM Free Cash Flow to Firm	-5	-11	-18	-45	-78	-68	-75	-81	-125	-132	-118	10	-23	1	2

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-19.03	-22.79	-32.76	-14.84	-22.89	-16.66	-16.48	-10.03	-4.2	-2.11	-1.02	5.39	-1.02	8.48	7.68
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.23	- -	- -	- -
Enterprise Value	127	311	701	643	1,780	1,003	1,180	828	701	531	288	24	30	12	17
Low Price	25.5	62.5	82.5	171	200	219.5	175	175.5	91	42.5	17.5	1.99	1.95	0.7	0.72
EV/Sales	60.67	81.55	79.9	42.81	88.39	51.84	70.34	51.43	14.11	8.18	111.75	0.34	22.75	6.83	5.78
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.01	25.48	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.45	- -	- -	- -
Price/Earnings Average	-13.28	-7	-13.93	-13.76	-13.49	-15.6	-15.05	-9.64	-5.07	-2.29	-2.45	0.79	-3.78	-9.86	-24.32
Price/Earnings High	-48.41	-9.39	-24.69	-24.88	-22.92	-22.19	-22.18	-13	-8.52	-4.4	-6.35	2.46	-6.59	-14.54	-49.61
Price/Earnings Low	-2.47	-3.26	-7.41	-9.44	-8.14	-9.58	-9.35	-5.96	-2.55	-1.28	-0.81	0.16	-1.98	-3.7	-14.64
Price/Book Value	-72.71	-215.84	13.81	14.36	29.26	8.9	10.06	9.39	71.32	-2.93	-1.65	1.51	0.89	0.36	0.7
Price/Book Value Average	-132.98	-186.86	8.23	16.07	18.7	11.03	9.39	14.01	106.79	-3.69	-4.87	2.64	1.47	0.79	0.52
Price/Book Value High	-484.73	-250.66	14.58	29.07	31.77	15.69	13.83	18.89	179.49	-7.08	-12.63	8.24	2.56	1.16	1.05
Price/Book Value Low	-24.72	-87.03	4.37	11.03	11.29	6.77	5.83	8.65	53.64	-2.05	-1.61	0.54	0.77	0.29	0.31
Price/Tangible Book Value	-70.16	-184.93	13.98	14.73	30.03	9.07	10.31	12.48	-18.6	-2.19	-1.54	1.88	1.12	0.43	0.82
Price/Tangible Book Value Average	-128.31	-160.1	8.33	16.49	19.19	11.24	9.62	18.61	-27.85	-2.76	-4.52	3.29	1.85	0.93	0.6
Price/Tangible Book Value High	-467.73	-214.76	14.76	29.82	32.6	15.99	14.17	25.08	-46.81	-5.31	-11.73	10.27	3.23	1.38	1.22
Price/Tangible Book Value Low	-23.85	-74.57	4.43	11.32	11.58	6.9	5.97	11.49	-13.99	-1.54	-1.49	0.67	0.97	0.35	0.36
Price/Sales	44.91	74.4	75.74	44.34	89.15	58.45	73.99	53.25	12.01	5.14	55.68	0.72	18.04	5.63	6.24
Price/Sales Average	82.13	64.41	45.13	49.64	56.97	72.43	69.02	79.44	17.98	6.48	163.9	1.26	29.87	12.21	4.58
Price/Sales High	299.38	86.4	79.95	89.78	96.81	103.03	101.67	107.07	30.22	12.45	425.37	3.94	52.04	18.01	9.34
Price/Sales Low	15.27	30	23.99	34.08	34.39	44.47	42.87	49.06	9.03	3.61	54.14	0.26	15.64	4.58	2.76
Price/Cash Flow	-18.88	-22.3	-32	-14.64	-22.72	-16.36	-16.3	-8.03	-3.6	-2.09	-1	5.39	-1.02	8.48	7.68
Price/Cash Flow Average	-34.53	-19.31	-19.07	-16.38	-14.52	-20.28	-15.21	-11.97	-5.39	-2.64	-2.96	9.44	-1.68	18.38	5.64
Price/Cash Flow High	-125.87	-25.9	-33.78	-29.64	-24.67	-28.84	-22.4	-16.14	-9.05	-5.06	-7.67	29.42	-2.94	27.11	11.5
Price/Cash Flow Low	-6.42	-8.99	-10.14	-11.25	-8.76	-12.45	-9.45	-7.39	-2.71	-1.47	-0.98	1.92	-0.88	6.9	3.39
Price/Free Cash Flow Average	-34.8	-19.73	-19.52	-16.61	-14.63	-20.65	-15.37	-14.96	-6.29	-2.66	-3	9.43	-1.68	18.38	5.64
Price/Free Cash Flow High	-126.83	-26.46	-34.58	-30.04	-24.85	-29.37	-22.65	-20.16	-10.58	-5.12	-7.79	29.41	-2.94	27.11	11.5
Price/Free Cash Flow Low	-6.47	-9.19	-10.37	-11.4	-8.83	-12.68	-9.55	-9.24	-3.16	-1.48	-0.99	1.92	-0.88	6.9	3.39
EV/Sales Average	110.08	70.67	45.11	48.33	55.32	65.85	65.11	79.41	20.69	9.64	228.64	0.91	35.82	13.41	4.12
EV/Sales High	398.44	94.62	84.69	90.18	96.25	96.55	99.49	108.93	34.16	16.13	511.07	3.72	60.31	19.21	8.89
EV/Sales Low	21.33	33.2	21.08	32.11	32.12	37.81	37.57	46.95	10.84	6.52	110.08	- -	20.1	5.79	2.3
EV/EBITDA Average	-42.79	-16.77	-15.37	-13.45	-13.09	-14.14	-14.11	-9.84	-6.86	-4.13	-7.46	5.36	-6.14	-6.63	-4.12
EV/EBITDA High	-154.87	-22.45	-28.86	-25.1	-22.77	-20.74	-21.56	-13.5	-11.32	-6.91	-16.68	21.95	-10.33	-9.49	-8.89
EV/EBITDA Low	-8.29	-7.88	-7.19	-8.94	-7.6	-8.12	-8.14	-5.82	-3.59	-2.79	-3.59	-0.88	-3.44	-2.86	-2.3
EV/EBIT Average	-42.35	-16.71	-15.34	-13.44	-13.08	-14.12	-14.07	-9.82	-6.79	-4.02	-7.39	5.96	-5.47	-4.88	-2.96
EV/EBIT High	-153.3	-22.37	-28.8	-25.07	-22.76	-20.71	-21.5	-13.47	-11.22	-6.73	-16.52	24.42	-9.21	-6.98	-6.37
EV/EBIT Low	-8.21	-7.85	-7.17	-8.93	-7.59	-8.11	-8.12	-5.8	-3.56	-2.72	-3.56	-0.98	-3.07	-2.1	-1.65
Last Price	75	155	260.5	222.5	518.5	288.5	302	190.5	121	60.5	18	5.59	2.25	0.86	1.63
High Price	500	180	275	450.5	563	508.5	415	383	304.5	146.5	137.5	30.5	6.49	2.75	2.44
Enterprise Value Average	230	270	396	726	1,114	1,275	1,092	1,278	1,027	625	588	64	47	24	12
Enterprise Value High	832	361	743	1,355	1,939	1,869	1,669	1,754	1,696	1,046	1,315	260	79	34	27
Enterprise Value Low	45	127	185	482	647	732	630	756	538	423	283	-10	26	10	7

Shares Outstanding	2	2	3	3	4	4	4	5	5	6	9	9	12	12	12
Diluted Weighted Avg Shares	1	2	3	3	3	4	4	5	5	6	8	9	10	12	12
Basic Weighted Avg Shares	1	2	3	3	3	4	4	5	5	6	8	9	10	12	12
Revenue per Share	1.67	2.08	3.44	5.02	5.82	4.94	4.08	3.58	10.08	11.77	0.32	7.75	0.12	0.15	0.26
EBITDA per Share	-4.3	-8.78	-10.09	-18.03	-24.58	-22.98	-18.83	-28.87	-30.41	-27.48	-9.9	1.31	-0.73	-0.31	-0.26
Operating Income per Share	-4.34	-8.81	-10.12	-18.05	-24.6	-23.01	-18.89	-28.93	-30.69	-28.21	-10	1.18	-0.82	-0.42	-0.36
Basic EPS, GAAP	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-21.66	12.41	-0.98	-0.19	-0.05
Basic EPS from Cont Ops	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-9.96	0.12	-0.74	-0.2	-0.06
Diluted EPS, GAAP	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-21.66	11.96	-0.98	-0.19	-0.05
Diluted EPS from Cont Ops	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-9.96	0.11	-0.74	-0.2	-0.06
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.97	-6.95	-8.14	-15.2	-22.82	-17.63	-18.53	-23.73	-33.63	-28.93	-17.93	1.04	-2.21	0.1	0.21
Free Cash Flow per Basic Share	-4	-7.1	-8.33	-15.41	-22.99	-17.95	-18.73	-28.47	-38.48	-29.22	-18.21	1	-2.21	0.1	0.21
Cash & Equivalents per Share	0.08	0.78	18.69	16.45	18.18	33.44	29.37	33.6	29.65	13.42	7.55	4.01	0.38	0.44	0.65
Book Value per Share	-1.03	-0.72	18.86	15.5	17.72	32.41	30.01	20.28	1.7	-20.68	-10.89	3.7	2.54	2.37	2.32
Tangible Book Value per Share	-1.07	-0.84	18.63	15.11	17.27	31.8	29.3	15.27	-6.5	-27.6	-11.72	2.97	2.01	2	2

TherapeuticsMD, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)